Gilead Seeks Approval for Combo Hepatitis C Drug

Published February 19, 2014

Gilead seeks approval for combo hepatitis C drug
The Foster City drugmaker said it asked the Food and Drug Administration on Monday to approve a daily, fixed-dose combination of Sovaldi and ledipasvir as a treatment for patients with the genotype 1 hepatitis C virus. About three-fourths of … Whole …
Read more on San Francisco Chronicle

Business digest
The American Association of Gynecologic Laparoscopists and the Surgical Review Corp. designated Longmont United Hospital as a Center of Excellence in Minimally Invasive Gynocology. Dr. Brian Nelson is director of the … The company also received a $ 60 …
Read more on Boulder County Business Report

Related Drug Treatment Centers Austin Texas Information…